Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K250578
    Date Cleared
    2025-04-01

    (33 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powder-free class I Nitrile Patient Examination Gloves which coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs. The subject devices are identical in design and formulation to the predicate gloves of K230121.

    AI/ML Overview

    The provided FDA 510(k) clearance letter pertains to Nitrile Examination Gloves Powder Free Tested for Use With Chemotherapy Drugs & Fentanyl Citrate (Blue & Black), a medical device. This type of device is classified as a Class I medical device and does not involve AI/ML technology. Therefore, many of the requested categories related to AI/ML device studies (e.g., sample sizes for test/training sets, ground truth establishment, MRMC studies, standalone performance, expert qualifications, adjudication methods, effect sizes) are not applicable.

    The acceptance criteria and device performance are primarily evaluated based on material properties, chemical permeation resistance, and biocompatibility, using established ASTM and ISO standards for examination gloves.

    1. Table of Acceptance Criteria and Reported Device Performance

    The device, "NITRILE EXAMINATION GLOVES POWDER FREE TESTED FOR USE WITH CHEMOTHERAPY DRUGS & FENTANYL CITRATE (BLUE & BLACK)", was tested against various physical, chemical, and biological criteria.

    Test CategoryCharacteristic / StandardAcceptance CriteriaReported Device Performance (Result)
    PreambleProduct CodeLZA, LZC, QDO, OPJLZA, LZC, QDO, OPJ
    Intended UseTo prevent contamination between patient and examinerMeets stated intended use
    DesignPowder Free, Non-Sterile, Ambidextrous, Beaded CuffPowder Free, Non-Sterile, Ambidextrous, Beaded Cuff
    ConstructionAmbidextrous, Polymer Coated or Chlorinated, Powder Free NitrileAmbidextrous, Polymer Coated or Chlorinated, Powder Free Nitrile
    Color DescriptionBlue & BlackBlue & Black
    MaterialNitrileNitrile
    Single UseYesYes
    PackagingPacked in Dispenser BoxesPacked in Dispenser Boxes
    SterilityNon-SterileNon-Sterile
    Freedom From HolesASTM D6319-19, ASTM D5151-19Meet requirement inspection level G-1, AQL 2.5Pass
    DimensionASTM D6319-19Length (XS), min. 220mmMeet 220mm min
    Length (S, M, L, XL), min. 230mmMeet 230mm min
    Thickness (palm/finger), min. 0.05mmMeet 0.05mm min
    Width (XS), 70 ± 10 mmMeet 70 ± 10 mm
    Width (S), 80 ± 10 mmMeet 80 ± 10 mm
    Width (M), 95 ± 10 mmMeet 95 ± 10 mm
    Width (L), 110 ± 10 mmMeet 110 ± 10 mm
    Width (XL), 120 ± 10 mmMeet 120 ± 10 mm
    Physical Properties (Before Ageing)ASTM D6319-19Tensile Strength, 14 MPa min.Meet 14MPa min.
    Ultimate Elongation, 500% min.Meet 500% min.
    Physical Properties (After Accelerated Aging)ASTM D6319-19Tensile Strength, 14 MPa min.Meet 14MPa min.
    Ultimate Elongation, 400% min.Meet 400% min.
    Residual Powder ContentASTM D6319-19, ASTM D6124-06Not more than 2 mg per gloveMeet 2mg/glove max.
    Biocompatibility - Primary Skin IrritationISO 10993-10Not a primary skin irritantPass (did not cause an irritant response)
    Biocompatibility - Skin SensitizationISO 10993-10Not a contact sensitizerPass (did not produce a skin sensitization effect)
    Biocompatibility - In Vitro CytotoxicityISO 10993-5:2009No adverse biological reactionModerate cytotoxicity reactivity at 6.0 cm²/mL extract concentrations and no cytotoxicity reactivity at 3.0 cm²/mL extract concentrations.
    Biocompatibility - Acute Systemic ToxicityISO 10993-11No adverse biological reactionPass (no adverse biological reaction)
    Chemotherapy Drug PermeationASTM D6978-05 (Reapproved 2019)Varies by drug (Breakthrough Detection Time)See detailed table below

    Detailed Chemotherapy Drug and Fentanyl Citrate Permeation Performance:

    Chemotherapy Drugs and Fentanyl CitrateConcentrationMinimum Breakthrough Detection Time (minutes) - Blue GloveMinimum Breakthrough Detection Time (minutes) - Black Glove
    *Carmustine (BCNU)3.3 mg/ml22.621.8
    Cisplatin1.0 mg/ml>240 min>240 min
    Cyclophosphamide (Cytoxan)20.0 mg/ml>240 min>240 min
    Dacarbazine10.0 mg/ml>240 min>240 min
    Doxorubicin HCL2.0 mg/ml>240 min>240 min
    Etoposide20.0 mg/ml>240 min>240 min
    Fluorouracil50.0 mg/ml>240 min>240 min
    Ifosfamide50.0 mg/ml>240 min>240 min
    Mitoxantrone2 mg/ml>240 min>240 min
    Paclitaxel6.0 mg/ml>240 min>240 min
    *Thio Tepa10.0 mg/ml43.917.7
    Vincristine Sulfate1.0 mg/ml>240 min>240 min
    Methotrexate25.0 mg/ml>240 min>240 min
    Mitomycin C.0.5 mg/ml>240 min>240 min
    Fentanyl Citrate100mcg/2ml>240 min>240 min
    *Warning: Do not use with Carmustine and Thiotepa due to extremely low permeation times.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the exact sample sizes for each test (e.g., number of gloves tested for permeation, holes, dimensions, etc.) but refers to adherence to the methodologies outlined in the specified ASTM and ISO standards. These standards typically define minimum sample sizes for material testing.

    • Data Provenance: The document states the applicant is from Malaysia (Careglove Global Sdn. Bhd.). The testing was conducted according to international standards (ASTM, ISO), implying the tests were performed in a controlled laboratory environment, likely by the manufacturer or a contracted lab. The data is non-clinical and derived from prospective testing of manufactured glove samples.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This device is not an AI/ML device that requires expert review for "ground truth" establishment in the context of diagnostic or interpretive tasks. The "ground truth" for material properties is established by the physical and chemical measurements themselves, according to standardized protocols and certified laboratory equipment.

    4. Adjudication Method for the Test Set

    Not applicable. This device is not an AI/ML device that requires adjudication for interpretations. Test results are objective measurements against predefined criteria.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    Not applicable. MRMC studies are relevant for diagnostic or interpretive AI/ML devices where human readers' performance is evaluated with and without AI assistance. This is a physical and chemical barrier device.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done

    Not applicable. This device is a passive physical barrier and does not involve any algorithms or software.

    7. The Type of Ground Truth Used

    The "ground truth" for this device is based on objective measurements of physical properties (e.g., length, thickness, tensile strength, elongation), chemical resistance (breakthrough detection time), and biological reactivity (biocompatibility tests), as defined by internationally recognized standards (ASTM, ISO). There is no subjective human "ground truth" in this context.

    8. The Sample Size for the Training Set

    Not applicable. This is not an AI/ML device that undergoes "training."

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. This is not an AI/ML device. The manufacturing process of the gloves is designed to meet the specified standards, and quality control ensures consistency, but this is not "training" in the context of AI/ML.

    Ask a Question

    Ask a specific question about this device

    K Number
    K230121
    Date Cleared
    2023-05-15

    (118 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Non-Sterile Nitrile Patient Examination Glove is made from synthetic rubber latex. It is single use and powderfree variation of the class I Nitrile Patient Examination Gloves which is coated by on-line polymer with mild on-line chlorination process. These processes modify the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder. The available sizes are X-Small, Medium, Large and X-Large. The Nitrile Examination Gloves Powder Free (Blue & Black) have been tested for Chemotherapy Drugs and Fentanyl Citrate.

    AI/ML Overview

    This document describes the testing for Nitrile Examination Gloves, focusing on their resistance to chemotherapy drugs and Fentanyl Citrate. The study assesses the gloves' physical properties, biocompatibility, and chemical permeation alongside the reported device performance.


    1. Table of Acceptance Criteria and Reported Device Performance

    Chemotherapy and Fentanyl Citrate Permeation (Minimum Breakthrough Detection Time)

    Chemotherapy DrugsConcentrationAcceptance Criteria (from ASTM D6978-05 implied by claim of use)Reported Device Performance (Blue Glove)Reported Device Performance (Black Glove)
    Carmustine (BCNU)3.3 mg/mlNo specific public acceptance criterion provided but tested22.6 minutes21.8 minutes
    Cisplatin1.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Cyclophosphamide (Cytoxan)20.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Dacarbazine10.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Doxorubicin HCl2.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Etoposide20.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Fluorouracil50.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Ifosfamide50.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Mitoxantrone2 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Paclitaxel6.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Thiotepa10.0 mg/mlNo specific public acceptance criterion provided but tested43.9 minutes17.7 minutes
    Vincristine Sulfate1.0 mg/mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    Fentanyl Citrate Injection100mcg/2mlNo specific public acceptance criterion provided but tested>240 minutes>240 minutes
    WarningAdvised against use if permeation time is too lowCarmustine, Thiotepa warningCarmustine, Thiotepa warning

    Physical Properties, Dimensional, and Biocompatibility Testing

    TestMethodAcceptance CriteriaReported Device Performance
    Freedom From HolesASTM D6319-19, D5151-19Requirement inspection level G-1, AQL 2.5Pass
    Dimension (Length, Thickness, Width)ASTM D6319-19Length: min. 220mm, 230mm. Thickness: min. 0.05mm. Width: 70-120mm (based on size)Pass (Meets requirements for various sizes)
    Physical Properties (Before Aging)ASTM D6319-19Tensile Strength: 14 MPa min. Ultimate Elongation: 500% min.Pass (Meets 14MPa min, 500% min)
    Physical Properties (After Aging)ASTM D6319-19Tensile Strength: 14 MPa min. Ultimate Elongation: 400% min.Pass (Meets 14MPa min, 400% min)
    Residual Powder ContentASTM D6319-19, D6124-06Not more than 2 mg per glovePass
    Primary Skin Irritation TestISO 10993-10Not a primary skin irritantPass (Did not cause an irritant response)
    Skin Sensitization TestISO 10993-10Not a contact sensitizerPass (Did not produce a skin sensitization effect)
    In Vitro Cytotoxicity TestISO 10993-5:2009No adverse biological reactionModerate cytotoxicity at 6.0 cm²/mL; No reactivity at 3.0 cm²/mL
    Acute Systemic ToxicityISO 10993-11No adverse biological reactionPass (No adverse biological reaction)

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the sample size (number of gloves) used for the permeation, physical property, or biocompatibility tests.
    The data provenance is not explicitly mentioned (e.g., country of origin, retrospective or prospective). However, the tests were conducted according to international standards (e.g., ASTM, ISO), which implies a standardized, prospective testing approach in a laboratory setting. The applicant is based in Malaysia.


    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This is not a study involving expert readers or ground truth established by medical professionals. The "ground truth" for this device is determined by objective, standardized laboratory measurements (e.g., chemical permeation time, physical properties, biological reactions) as defined by the referenced ASTM and ISO standards.


    4. Adjudication Method for the Test Set

    Not applicable. There was no human adjudication process involved as the "ground truth" is determined by objective laboratory measurements and adherence to specified test standards.


    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done

    No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic devices that involve human interpretation of medical images or data. The device in question is examination gloves, and its performance is evaluated through physical, chemical, and biological testing, not by human readers interpreting cases.


    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done

    Not applicable. This is a medical device (examination gloves), not an AI algorithm. Therefore, the concept of "standalone" performance for an algorithm does not apply. All listed tests are "standalone" in the sense that they assess the intrinsic properties of the glove without human intervention in the measurement process itself, though human technicians conduct and analyze the tests.


    7. The Type of Ground Truth Used

    The ground truth used for this study is based on:

    • Performance Standards: Defined by international standards such as ASTM D6978-05 (for chemotherapy drug permeation), ASTM D6319-19, ASTM D5151-19, ASTM D6124-06 (for physical properties and hole freedom), and ISO 10993-10, ISO 10993-5:2009, ISO 10993-11 (for biocompatibility).
    • Objective Laboratory Measurements: Direct measurements of breakthrough time, dimensional properties, tensile strength, elongation, residual powder, and biological response to the glove materials.

    8. The Sample Size for the Training Set

    Not applicable. There is no training set mentioned or implied in this submission, as the device is not an AI/ML algorithm that requires training data.


    9. How the Ground Truth for the Training Set was Established

    Not applicable, as there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K211666
    Date Cleared
    2022-01-09

    (222 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    It is the powder-free variation of the class I latex patient examination gloves made by on-line polymer-coating and mild on-line chlorination process modifies the surface characteristics and causes it to remain tack-free without the use of any dusting or donning powder.

    AI/ML Overview

    This is a 510(k) summary for a medical device (Powder Free Nitrile Examination Gloves, Blue, Chemotest), not an AI/ML device. Therefore, the sections regarding AI/ML device assessment criteria (such as sample size for test/training set, number of experts for ground truth, adjudication methods, MRMC studies, standalone performance, and ground truth types) are not applicable.

    The document focuses on demonstrating substantial equivalence to a predicate device through non-clinical performance and biocompatibility testing.

    Here's the relevant information extrapolated from the document regarding acceptance criteria and performance:

    1. Table of Acceptance Criteria and Reported Device Performance

    CharacteristicStandardAcceptance CriteriaReported Device Performance
    Freedom From HolesASTM D6319-19, ASTM D5151-19Inspection level G-I, AQL 2.5Pass
    DimensionASTM D6319-19Length, min. (mm): XSmall 220, Small 220, Medium 230, Large 230, XLarge 230Pass (Meets requirements for all sizes)
    Thickness, min. (mm): 0.05 (palm, finger)Pass (Meets 0.05mm min)
    Width, ± 10 (mm): XSmall 70, Small 80, Medium 95, Large 110, XLarge 120Pass (Meets requirements for all sizes)
    Physical Properties (Before Aging)ASTM D6319-19Tensile Strength: 14 MPa min.Pass (Meets 14MPa min.)
    Ultimate Elongation: 500 % min.Pass (Meets 500% min.)
    Physical Properties (After Accelerated Aging)ASTM D6319-19Tensile Strength: 14 MPa min.Pass (Meets 14MPa min.)
    Ultimate Elongation: 400 % min.Pass (Meets 400% min.)
    Residual Powder ContentASTM D6319-19, ASTM D6124-06Not more than 2 mg per glovePass (Meets 2mg/glove max.)
    Biocompatibility - Primary Skin Irritation TestISO 10993-10No IrritationNo irritant response
    Biocompatibility - Skin Sensitization TestISO 10993-10No IrritationNo skin sensitization effect
    Biocompatibility - In Vitro Cytotoxicity TestISO 10993-5:2009(No specific numerical criteria, evaluated for reactivity)Moderate cytotoxicity reactivity at 6.0 cm²/mL; No cytotoxicity reactivity at 3.0 cm²/mL
    Biocompatibility - Acute Systemic ToxicityISO 10993-11(No specific numerical criteria, evaluated for adverse biological reactions)No adverse biological reaction
    Chemotherapy Drugs Permeation TimeASTM D6978-05(Breakthrough detection time in minutes per drug)Carmustine (BCNU): 22.6 min (WARNING: Not recommended for use) Cisplatin: >240 min Cyclophosphamide (Cytoxan): >240 min Dacarbazine: >240 min Doxorubicin HCL: >240 min Etoposide: >240 min Fluorouracil: >240 min Ifosfamide: >240 min Mitoxantrone: >240 min Paclitaxel: >240 min Thio Tepa: 43.9 min (WARNING: Not recommended for use) Vincristine Sulfate: >240 min

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not explicitly state the sample sizes for each non-clinical test (e.g., number of gloves tested for dimensions, holes, or physical properties). However, it implies that the testing was conducted according to the specified ASTM and ISO standards, which would dictate appropriate sample sizes for each test method.

    The data provenance is not explicitly stated in terms of country of origin of the testing data itself, but the applicant is Careglove Global SDN BHD from Malaysia. The studies are non-clinical, laboratory-based tests.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable, as this is for a physical medical device (examination gloves) and not an AI/ML diagnostic or predictive device requiring ground truth from human experts. The "truth" is established by physical measurement against standard specifications.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This concept applies primarily to AI/ML clinical studies where human readers might adjudicate discrepancies or define ground truth. For physical device testing, results are measured and compared against established standards.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable, as this is not an AI/ML device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable, as this is not an AI/ML device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" or reference values for device performance are defined by recognized international and national standards:

    • ASTM D6319-19 (Standard Specification for Nitrile Examination Gloves for Medical Application)
    • ASTM D5151-19 (Standard Test Method for Detection of Holes in Medical Gloves)
    • ASTM D6124-06 (Standard Test Method for Residue on Medical Gloves)
    • ASTM D6978-05 (Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs)
    • ISO 10993-10 (Biological evaluation of medical devices – Part 10: Tests for irritation and skin sensitization)
    • ISO 10993-5:2009 (Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity)
    • ISO 10993-11 (Biological evaluation of medical devices – Part 11: Tests for systemic toxicity)

    The device's performance is compared directly to the specifications outlined in these standards.

    8. The sample size for the training set

    Not applicable, as this is not an AI/ML device and therefore does not have a "training set."

    9. How the ground truth for the training set was established

    Not applicable, as this is not an AI/ML device and therefore does not have a "training set" with established ground truth.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1